Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

GLP-1 Sales Continue to Lift Eli Lilly. Does That Make LLY Stock a Buy?

Eli Lilly (LLY) shares closed comfortably in the green on Thursday as strong GLP-1 sales helped the pharmaceutical behemoth report a blockbuster Q1 and raise guidance for the full year. 

According to the earnings release, LLY’s combined revenue from Zepbound and Mounjaro more than doubled year-over-year to $12.82 billion in the first quarter. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.